Noema.png
Noema Pharma raises CHF54 million in Series A financing round led by Sofinnova Partners and Polaris Partners
December 01, 2020 02:00 ET | Noema Pharma
In-licensing of four clinical-stage product candidates to treat orphan neurological disordersHighly experienced team leverages latest scientific discoveries in neuroscienceFinancing will advance the...